Monthly video series highlights the agency’s run-ins with questionable products through the decades
New regulations on combination products, and an unknown future as new chair appointment still pending
A proactive approach in a high-risk sector
Progress and potential report
A new path for pharmaceutical inspections in Europe and beyond
It was a busy year for Health and Human Services
What to know—and avoid
A life-cycle approach for monitoring cybersecurity vulnerabilities
New international Meddev rules challenge complacent organizations
One size does not fit all
The agency’s 2017 goals featured at regulatory professionals conference
A key link in the safety chain
Embrace the total product life cycle
Creating global alliances to meet the challenge
Building out a national system for evidence generation
The curious logic behind prescription drug names
Understand the importance of three overlooked parts: 820, 803, and 806
Laying the foundation for a national system for clinical evidence generation
Robots lighten the laboratory load
A laboratory quality management system is key